Dermatologic adverse events associated with targeted therapies for melanoma.

Scarpato, Luigi; Festino, Lucia; Vanella, Vito; Madonna, Gabriele; Mastroianni, Massimo; Palla, Marco; Ascierto, Paolo Antonio

Scarpato, Luigi; Festino, Lucia; Vanella, Vito; Madonna, Gabriele; Mastroianni, Massimo; Palla, Marco; Ascierto, Paolo Antonio.

Afiliación

Scarpato L; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Festino L; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Vanella V; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Madonna G; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Mastroianni M; Department of Otolaryngology Surgery and Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Palla M; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Ascierto PA; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.

Expert Opin Drug Saf ; 21(3): 385-395, 2022 Mar.

Article en En | MEDLINE | ID: mdl-34595993

Asunto(s)

Melanoma; Neoplasias Cutáneas; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Humanos; Melanoma/patología; Terapia Molecular Dirigida/efectos adversos; Mutación; Inhibidores de Proteínas Quinasas/uso terapéutico; Proteínas Proto-Oncogénicas B-raf/genética; Calidad de Vida; Neoplasias Cutáneas/patología

Palabras clave

BRAF inhibitors; MEK inhibitors; Melanoma; adverse events; cutaneous toxicity; skin; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Expert Opin Drug Saf Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google